Additionally, some CD47 antibodies are limited to hematological tumors and require combination with other antibodies.[31, 63] IgG4 antibodies against CD47 are ineffective against solid tumors, possibly due to CD47's expression on erythrocytes, which depletes the antibody before it can reach tumor cells. The gene discussed is CD47; the disease is hematopoietic and lymphoid cell neoplasm.